CAS 1088543-62-7

AZP-531

CAS: 1088543-62-7

Azp-531 is a disacylated ghrelin used to improve blood sugar control and weight loss.

Formula: C₄₀H₆₃N₁₅O₁₃

Purezza: 98%

Colore e forma: Solid

Peso molecolare: 962.02

Ref: TM-TP1439

AZP-531

CAS: 1088543-62-7

AZP-531 is a drug that has been shown to have pharmacokinetic properties and pharmacodynamics in humans. It has a terminal half-life of about 7 hours, which is shorter than the half-life of most drugs. AZP-531 binds to the myocardium and mesentery and can be used to treat metabolic disorders such as obesity. This drug has also been shown to inhibit protein synthesis in animals, but not humans. The drug was well-tolerated by healthy volunteers with no serious adverse effects reported. AZP-531 is an analog of rapamycin, a macrolide antibiotic that was originally developed for cancer therapy but was found ineffective for this purpose. Rapamycin inhibits cell growth by binding to the immunophilin FKBP12, which prevents the mTOR kinase from associating with its substrate S6K1 and phosphorylating it. AZP-531 may have potential as an anti-cancer agent

Formula: C₄₀H₆₃N₁₅O₁₃

Purezza: Min. 95%

Peso molecolare: 962 g/mol

Ref: 3D-NTB54362